In this issue:
Characteristics of CAR-T therapy-associated infections
Inpatient versus outpatient administration of axi-cel
Cognitive recovery for those with ICANS
Differences in clinical outcomes for older and younger patients
Implementation of tali-cel
Expansion of the lymphocyte population and its prognostic information
Comparison between PV-R and PV-BR
Efficacy and safety of liso-cel
Infection burden associated with CAR-T therapy
GUCY2C CAR-T therapy
Please login below to download this issue (PDF)